Kotzan JA - Search Results

1

Bioavailability of regular and controlled-release chlorpheniramine products.

Kotzan JA, Vallner JJ, Stewart JT, Brown WJ, Viswanathan CT, Needham TE, Dighe SV, Malinowski R. Kotzan JA, et al. J Pharm Sci. 1982 Aug;71(8):919-23. doi: 10.1002/jps.2600710820. J Pharm Sci. 1982. PMID: 7120098

2

Blood levels following multiple oral dosing of chlorpheniramine conventional and controlled release preparations.

Vallner JJ, Kotzan JA, Stewart JT, Brown WJ, Honigberg IL, Needham TE, Dighe SV. Vallner JJ, et al. Among authors: kotzan ja. Biopharm Drug Dispos. 1982 Apr-Jun;3(2):95-104. doi: 10.1002/bdd.2510030203. Biopharm Drug Dispos. 1982. PMID: 7104467 Clinical Trial.

3

Correlation of aspirin excretion with parameters from different dissolution methods.

Needham TE, Shah K, Kotzan J, Zia H. Needham TE, et al. J Pharm Sci. 1978 Aug;67(8):1070-3. doi: 10.1002/jps.2600670812. J Pharm Sci. 1978. PMID: 671239

4

Examination of blood clobazam levels and several pupillary measures in humans.

Kotzan JA, Needham TE, Honigberg IL, Vallner JJ, Stewart JT, Brown WJ, Jun HW. Kotzan JA, et al. J Pharm Sci. 1979 Aug;68(8):1002-4. doi: 10.1002/jps.2600680822. J Pharm Sci. 1979. PMID: 480152

5

An in vivo single- and multiple-dose study of several marketed brands of conventional and controlled-release theophylline.

Kotzan JA, Vallner JV, Stewart JT, Honigberg IL, Brown WJ. Kotzan JA, et al. Drug Intell Clin Pharm. 1984 Feb;18(2):147-53. doi: 10.1177/106002808401800212. Drug Intell Clin Pharm. 1984. PMID: 6697877

6

Plasma levels of clobazam after three oral dosage forms in health subjects.

Vallner JJ, Needham TE, Jun HW, Brown WJ, Stewart JT, Kotzan JA, Honigberg IL. Vallner JJ, et al. Among authors: kotzan ja. J Clin Pharmacol. 1978 Jul;18(7):319-24. doi: 10.1002/j.1552-4604.1978.tb01600.x. J Clin Pharmacol. 1978. PMID: 27537

7

Bioequivalency and dose proportionality of three tableted promethazine products.

Zaman R, Honigberg IL, Francisco GE, Kotzan JA, Stewart JT, Brown WJ, Shah VP, Pelsor FR. Zaman R, et al. Among authors: kotzan ja. Biopharm Drug Dispos. 1986 May-Jun;7(3):281-91. doi: 10.1002/bdd.2510070309. Biopharm Drug Dispos. 1986. PMID: 3730528 Clinical Trial.

8

Plasma levels of clobazam after 10-, 20-, and 40-mg tablet doses in healthy subjects.

Vallner JJ, Kotzan JA, Stewart JT, Honigberg IL, Needham TE, Brown WJ. Vallner JJ, et al. Among authors: kotzan ja. J Clin Pharmacol. 1980 Jul;20(7):444-51. doi: 10.1002/j.1552-4604.1980.tb01717.x. J Clin Pharmacol. 1980. PMID: 6107307

9

Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects.

Vallner JJ, Stewart JT, Kotzan JA, Kirsten EB, Honigberg IL. Vallner JJ, et al. Among authors: kotzan ja. J Clin Pharmacol. 1981 Apr;21(4):152-6. doi: 10.1002/j.1552-4604.1981.tb05693.x. J Clin Pharmacol. 1981. PMID: 6165742

10

In vitro and in vivo bioequivalence of commercial prednisone tablets.

Francisco GE, Honigberg IL, Stewart JT, Kotzan JA, Brown WJ, Schary WL, Pelsor FR, Shah VP. Francisco GE, et al. Among authors: kotzan ja. Biopharm Drug Dispos. 1984 Oct-Dec;5(4):335-44. doi: 10.1002/bdd.2510050405. Biopharm Drug Dispos. 1984. PMID: 6525441 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters